Effects of caspofungin, tolcapone and other FDA-approved medications on MRSA susceptibility to vancomycin

Effects of caspofungin, tolcapone and other FDA-approved medications on MRSA susceptibility to vancomycin

Objectives: Vancomycin is a first-line antibiotic for the treatment of invasive infections in humans caused by methicillin-resistant Staphylococcus aureus (MRSA). Based on the premise that antibiotic combinations can exhibit synergistic and antagonistic interactions, medications used for the treatme...

Full description

Bibliographic Details
Main Authors: Jonah A. Moore, Michaela Meakin, Mikaela H. Earl, Tiffany M. Kummer, Jeremy P. McAleer, Timothy E. Long
Format: Article
Language:English
Published: Elsevier 2020-09-01
Series:Journal of Global Antimicrobial Resistance
Subjects:
MRSA
Antibiotics
Vancomycin
Caspofungin
Tolcapone
Flow cytometry
Online Access:http://www.sciencedirect.com/science/article/pii/S2213716520300783

Internet

http://www.sciencedirect.com/science/article/pii/S2213716520300783

Similar Items